Product NDC: | 0430-0115 |
Proprietary Name: | DORYX |
Non Proprietary Name: | doxycycline hyclate |
Active Ingredient(s): | 150 mg/1 & nbsp; doxycycline hyclate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0430-0115 |
Labeler Name: | Warner Chilcott (US), LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050795 |
Marketing Category: | NDA |
Start Marketing Date: | 20110921 |
Package NDC: | 0430-0115-20 |
Package Description: | 48 BOTTLE in 1 CASE (0430-0115-20) > 60 TABLET, DELAYED RELEASE in 1 BOTTLE |
NDC Code | 0430-0115-20 |
Proprietary Name | DORYX |
Package Description | 48 BOTTLE in 1 CASE (0430-0115-20) > 60 TABLET, DELAYED RELEASE in 1 BOTTLE |
Product NDC | 0430-0115 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | doxycycline hyclate |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110921 |
Marketing Category Name | NDA |
Labeler Name | Warner Chilcott (US), LLC |
Substance Name | DOXYCYCLINE HYCLATE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes |